Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering
ACS Chemical Biology · 2024-02-16 · 19 (2) · 506-515
DOI: 10.1021/acschembio.3c00685 ↗At a glance
Journal article in ACS Chemical Biology, published online on 2024-01-24. Written by Yi Wolf Zhang and 5 co-authors. Institution: Department of Pediatrics, Division of Diabetes and Endocrinology, Stanford University, Palo Alto, California 94304, United States. Major MEDLINE topics: Peptide Library, Bacteriophages. Cited 5 times so far (Crossref); 56 references. Funded by: NIDDK NIH HHS, NIGMS NIH HHS, Lilly Endowment.
Abstract (original language)
Chemical and enzymatic modifications of peptide-displayed libraries have been successfully employed to expand the phage display library. However, the requirement of specific epitopes and scaffolds has limited the scope of protein engineering using phage display. In this study, we present a novel approach utilizing omniligase-1-mediated selective and specific ligation on the phage pIII protein, offering a high conversion rate and compatibility with commercially available phage libraries. We applied this method to perform high-throughput engineering of insulin analogues with randomized B chain C-terminal regions. Insulin analogues with different B chain C-terminal segments were selected and exhibited biological activity equivalent to that of human insulin. Molecular dynamics studies of insulin analogues revealed a novel interaction between the insulin B27 residue and insulin receptor L1 domain. In summary, our findings highlight the potential of omniligase-1-mediated phage display in the development and screening of disulfide-rich peptides and proteins. This approach holds promise for the creation of novel insulin analogues with enhanced therapeutic properties and exhibits potential for the development of other therapeutic compounds.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Pediatrics, Division of Diabetes and Endocrinology, Stanford University, Palo Alto, California 94304, United States.
- Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112, United States.
- Department of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
ORCID profiles: Yi Wolf Zhang, Peter J Ortoleva, Danny Hung-Chieh Chou
Funding
- NIDDK NIH HHS
- NIGMS NIH HHS
- Lilly Endowment
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of General Medical Sciences
Cite
APA
Zhang, Y. W., Lin, N. P., Guo, X., Szabo-Fresnais, N., Ortoleva, P. J., & Chou, D. H. (2024). Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering. ACS Chemical Biology, 19(2), 506-515. https://doi.org/10.1021/acschembio.3c00685
Vancouver
Zhang YW, Lin NP, Guo X, Szabo-Fresnais N, Ortoleva PJ, Chou DH. Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering. ACS Chemical Biology. 2024;19(2):506-515. doi:10.1021/acschembio.3c00685
BibTeX
@article{Zhang2024,
author = {Zhang, Yi Wolf and Lin, Nai-Pin and Guo, Xu and Szabo-Fresnais, Nicolas and Ortoleva, Peter J and Chou, Danny Hung-Chieh},
title = {Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering},
journal = {ACS Chemical Biology},
year = {2024},
volume = {19},
number = {2},
pages = {506--515},
doi = {10.1021/acschembio.3c00685}
}
EUVIMED